Cost analysis of adjuvant management strategies in early stage (stage I) testicular seminoma

Keyphrases

• Additional Therapy 16%
• Adjuvant Management 100%
• Adjuvant Therapy 33%
• Carboplatin 50%
• Cause-specific Survival 16%
• Clinical Judgment 16%
• Close Analysis 16%
• Cost Analysis 100%
• Dogleg 50%
• Follow-up Recommendations 33%
• Incremental Cost-effectiveness Ratio 33%
• Inguinal Orchiectomy 16%
• Management Strategy 100%
• Medicare Reimbursement 16%
• Model Observations 16%
• National Comprehensive Cancer Network 66%
• National Comprehensive Cancer Network Guidelines 16%
• Orchiectomy 16%
• Radiation Therapy 100%
• Reimbursement 66%
• Reimbursement Rates 16%
• Stage I Seminoma 66%
• Surveillance Guidelines 16%
• Testicular Seminoma 100%
• Therapy Dogs 50%
• Therapy Strategy 16%
• Treatment Options 16%
• Treatment Plan 16%
• Treatment Strategy 50%

Medicine and Dentistry

• Adjuvant Therapy 33%
• Carboplatin 50%
• Cause Specific Survival 16%
• Cost Benefit Analysis 100%
• Cost-Effectiveness Analysis 33%
• Health Care Cost 33%
• Inguinal Orchiectomy 16%
• Leg 50%
• Malignant Neoplasm 83%
• Medicare 16%
• Orchiectomy 16%
• Radiation Therapy 100%
• Seminoma 100%